Meet Kathryn Fantauzzi, Chief Executive Officer, Co-Founder
Kathryn Fantauzzi is the chief executive officer and co-founder at Apollo Neuroscience, Inc. where she leads all Apollo strategy and development. Kathryn is experienced in leading cross-functional teams to bring products and services to market. As CEO, she recruited a seasoned team of business leaders, engineers, designers, and physicians with multiple prior exits to launch Apollo. Prior to Apollo, Kathryn managed a $20M fund to evaluate and advance commercialization of emerging technologies for NYSERDA. Kathryn formed Apollo Neuroscience in 2017 to accelerate the development and translation of novel neuroscience discoveries to address public health needs and improve outcomes.
